Richard Shea
Director/Miembro de la Junta en SYNLOGIC, INC. .
Fortuna: 930 $ al 30/04/2024
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Aoife Brennan | M | 48 |
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 8 años |
| Michael Metzger | M | 53 | 9 años | |
| Nick Leschly | M | 51 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 8 años |
| Peter Barrett | M | 71 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 13 años |
| Michael Powell | M | 69 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 7 años |
| Mary Dooley | F | 43 | 6 años | |
| Ed Mathers Mathers | M | 64 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 12 años |
| Chau Khuong | M | 48 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 6 años |
| Michael Heffernan | M | 59 | 4 años | |
| Pierre Legault | M | 63 | 7 años | |
| William Meury | M | 56 | 6 años | |
| Luke Albrecht | M | 45 | 8 años | |
| James Collins | M | 58 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 10 años |
| Timothy Lu | M | 43 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 10 años |
| Jennifer Jarrett | F | 53 | 6 años | |
| Thomas J. Adam | M | - | 7 años | |
| Brendan St Amant | M | - | 3 años | |
| Keith Katkin | M | 52 | 7 años | |
| Jo-Ann Beltramello | F | - | 17 años | |
| Molly Harper | F | 48 | 3 años | |
| Caroline Kurtz | M | - | 8 años | |
| Anjali Ganguli | M | 48 | 9 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Craig Wheeler | M | 63 | 14 años | |
| Jose-Carlos Gutiérrez-Ramos | M | 61 | 5 años | |
| Antoine Awad | M | 44 | 6 años | |
| John S. Pallies | M | 60 | 9 años | |
| Briggs Morrison | M | 65 | 9 años | |
| Allan Shaw | M | 59 | 1 años | |
| Todd Shegog | M | 59 | 3 años | |
| Bruce Downey | M | 76 | 11 años | |
| Jay Mohr | M | - |
Variagenics, Inc.
 Variagenics, Inc. Miscellaneous Commercial ServicesCommercial Services Variagenics, Inc. develops molecular diagnostic tests by identifying genetic markers associated with response to cancer therapies, with the goal of optimizing patient care through both biopharmaceutical collaborations and its own internal research programs | 2 años |
| Leonard Patrick Gage | M | 81 |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 9 años |
| Alexander Nolte | M | 52 | 6 años | |
| Arlene Morris | F | 72 | 4 años | |
| Christoph Westphal | M | 56 | 5 años | |
| Ram Sasisekharan | M | 58 | 9 años | |
| Ben Shapiro | M | 84 | 13 años | |
| Kim Kamdar | M | 56 | 11 años | |
| George W. Sledge | M | 73 | 3 años | |
| Michael Meyers | M | 74 | 7 años | |
| Steven Gilman | M | 71 | 4 años | |
| Ivor Royston | M | 79 | 4 años | |
| Thomas Paul Koestler | M | 72 | 9 años | |
| Corey Fishman | M | 59 | 4 años | |
| Elizabeth Stoner | M | 73 | 13 años | |
| Young Kwon | M | 52 | 10 años | |
| Luke Evnin | M | 60 | 6 años | |
| Marsha Fanucci | F | 70 | 11 años | |
| Henry Chen | M | 53 | 3 años | |
| James Sulat | M | 73 | 11 años | |
| Scott M. Storer | M | - | 2 años | |
| Robert Langer | M | 74 | 8 años | |
| Georges Gemayel | M | 63 | 4 años | |
| Patricia Hurter | M | 60 | 5 años | |
| Bruce A. Leicher | M | 68 | 10 años | |
| Peter Hutt | M | 89 | 13 años | |
| Lisa Kelly-Croswell | F | 57 | 3 años | |
| John Clarke | M | 70 | 13 años | |
| Lisa Carron Shmerling | F | 63 | - | |
| Michael Burgess | M | 61 | 4 años | |
| Richard Riese | M | 61 | 2 años | |
| Michael Morneau | M | 58 | 2 años | |
| Andrew Marsh | M | - | 1 años | |
| Philip Nickson | M | 45 | 9 años | |
| Erin Moore | F | 49 | 2 años | |
| Matthew P. Ottmer | M | 53 | 2 años | |
| Anthony Manning | M | 62 | - | |
| Nic G. Scalfarotto | M | - | - | |
| Robert D. Ciappenelli | M | 57 | 2 años | |
| Steven Fruchtman | M | 73 | 1 años | |
| David L. Hava | M | 49 | 3 años | |
| R. Adams | M | 57 |
Variagenics, Inc.
Variagenics, Inc. Miscellaneous Commercial ServicesCommercial Services Variagenics, Inc. develops molecular diagnostic tests by identifying genetic markers associated with response to cancer therapies, with the goal of optimizing patient care through both biopharmaceutical collaborations and its own internal research programs | 5 años |
| Narinder Singh | M | 51 | 3 años | |
| Jamie Austin | M | - | - | |
| John L. Knopf | M | 71 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 16 años |
| Thomas Spitznagel | M | 57 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 4 años |
| Robert H. Tidwell | M | 80 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 5 años |
| Melissa A. Kelly Behrs | F | 59 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 8 años |
| Zoltan A. Csimma | M | 82 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 10 años |
| Steven B. Brugger | M | 65 | 8 años | |
| Elizabeth A. Olek | M | 59 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 4 años |
| Ramani Varanasi | F | 54 | - | |
| John L. Zabriskie | M | 85 | - | |
| Gabriel Schmergel | M | 83 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 15 años |
| Paul S. Miller | M | 65 | - | |
| Thomas D. Kiley | M | 80 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 8 años |
| Jeffrey S. Stubbs | M | 61 | - | |
| Gregg Beloff | M | 56 | 3 años | |
| Gary Hattersley | M | 57 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 8 años |
| Michael R. Slater | M | 77 | 2 años | |
| Catharine E. Johnson | M | - | - | |
| Stephen T. Reeders | M | 70 | 5 años | |
| Stephen Albert Martin | M | 54 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 5 años |
| Adelene Perkins | F | 54 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 7 años |
| John W. Loewy | M | - |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 5 años |
| Daphne Karydas | F | 49 | 1 años | |
| Paul David Goldenheim | M | - | - | |
| Caryn Peterson | F | 65 | 10 años | |
| Michael F. Jarvis | M | - |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 8 años |
| Michael Jensen | M | 48 | 1 años |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Estados Unidos | 100 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Richard Shea
- Red Personal
